ALFA FinderBSE filing, NSE: RHIM. Summary written from the filing by ALFA Finder's alert engine.
RHI Magnesita India Ltd: key numbers
- Share price
- ₹365.50
- Market cap
- ₹7,548 Cr
- Revenue (annual)
- ₹4,020 Cr
- Net profit (annual)
- ₹-382.9 Cr
- P/E (TTM)
- -21.4×Sector 51.9×
- Promoter holding
- 56.07%+0.00% QoQ
- FII holding
- 3.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RHI Magnesita India Ltd
All →RHI Magnesita India Board Meeting Date
RHI Magnesita India has called a board meeting on November 13, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The filing is an advance notice with no results figures disclosed.
RHI Magnesita India Other Announcement
The company filed its quarterly shareholding pattern statement for the quarter ended September 30, 2026, as per regulatory requirements.
RHI Magnesita India Management Change
RHI Magnesita India Ltd. announced the appointment of Mr. Pankaj Malhan as Managing Director and CEO for a five-year term, effective July 1, 2026.
- Execution
- 5 years
RHI Magnesita India Other Announcement
RHI Magnesita India Ltd. appointed M/s. B S R & Co. LLP as its Statutory Auditor for five years, following approval at the 16th AGM.
- Execution
- 5 years
RHI Magnesita India Annual General Meeting
RHI Magnesita India Limited conducted its 16th Annual General Meeting on September 29, 2026. Shareholders considered resolutions for audited financial statements, a final dividend, and director appointments.
RHI Magnesita India Capital Structure Change
Dalmia Bharat Refractories, a non-promoter, disposed of its entire 2,70,20,000 RHI Magnesita India stake (13.08%) via open market. The position after sale is Nil.
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.